ERBB2 and breast cancer: By identifying four molecular subtypes of BC—Luminal A, Luminal B, Human Epidermal Growth Factor Receptor 2 (HER2-enriched or c-ERBB2), and basal-like [25–27] gene expression profiling has fundamentally altered our understanding of the disease.